ANNUAL REPORT 06 - Bosnalijek dd

More documents

Recommendations

Info

In total sale of medicines from our own product programme, prescriptionmedicines had a share of 83.59%, and non-prescription medicines (OTCprogramme) the remaining share of 16.41%.A trend of high growth of sale of OTC programme was continued, whichfaced an increase of sale in 2006 of 33.30% in relation to year 2005, as aconfirmation that medications for self-treatment are gaining more andmore significance due to increase of consumers awareness about the needfor taking care about their own health and preventing an illness.Leading positions in value of sale in B osnalijek por tfolio were taken byLopril®H, Lopril®, Lysobac t®, R anibos®, X i c l a v ® , E n t e r o f u r y l ® , Av a m i g r a n ® ,S t o m a t i d i n ® , Nitroglicerol®, Paracetamol, Dilatrend® and Rhinostop®.20 ANNUAL REPORT 06 MARKETING AND SALE
14% J-ANTIINFECTIVES2% M-MUSCULO-SKELETAL SYSTEM14% N-NERVOUS SYSTEM1% D-DERMATOLOGICALS3% -OTHER MEDICATIONS22% A-DIGESTIVE TRACT AND METABOLISM2% R-RESPIRATORY SYSTEM42% C-CARDIOVASCULAR SYSTEMSTRUCTURE BY PFARMACOTHERAPEUTIC GROUPSA continuous growth of sale of OTC programme and accomplished share of16.41% in total value of medicines sale, is especially generated by ourproducts Lysobact®, Stomatidin®, Paracetamol and Rhinostop®, as well asRoyal Jelly® that was accepted as excellent and quite demandedsupplement to nutrition at all markets, after target marketing activities.Cardiovascular medicines, digestives and antiinfectives are leadingpharmacotherapeutic groups of medicines by value of sale, by whichcoordination of Bosnalijek portfolio with the structure of world consumptionof medicines by indication areas is confirmed.Cardiovascular medicines are the leading medicines of B osnalijekpharmaceutical programme, which are followed by medicationsac ting on digestive system and metabolism, medicines for treatingsystemic infec tions and those ac ting on the ner vous system.serving Your health MARKETING AND SALE ANNUAL REPORT 06 21
Page 1: ANNUAL REPORT 06
Page 5 and 6: “It is my pleasure to mention the
Page 7 and 8: BASIC FINANCIAL INDICATORS 2006Bosn
Page 9 and 10: INFORMATION FOR INVESTORSIn end of
Page 11 and 12: PRINCIPLES OF THE CORPORATE MANAGEM
Page 13 and 14: MVSMISSION VISION STRATEGYBjelašni
Page 15 and 16: Supervisory Board of Bosnalijek d.d
Page 17: STRUCTURE OF MARKET 2006.80% DOMEST
Page 21 and 22: O ur own programmes take par t in t
Page 23 and 24: INTERNATIONAL MARKETSSale at intern
Page 25 and 26: 1% SLOVENIA16% CROATIA31% KOSOVO4%
Page 27 and 28: 51% LIBIYA24% KUWAIT19% QATAR6% YEM
Page 29 and 30: As a part of new Bosnalijek Product
Page 31 and 32: Registrations in Bosnia and Herzego
Page 33 and 34: Responsibility towards environmentA
Page 35 and 36: ENVIRONMENT GUIDELINES OFBOSNALIJEK
Page 37 and 38: HUMAN RESOURCESBiggest value of Bos
Page 39 and 40: SOCIAL RESPONSIBILITYThrough managi
Page 41 and 42: We are proud of our SOS family in
Page 43 and 44: REPORT OF AUDITING BOARD FOR YEAR 2
Page 45 and 46: RESPONSIBILITY FOR THE FINANCIAL ST
Page 47 and 48: Bosnalijek d.d.Statement of income
Page 49 and 50: Bosnalijek d.d.Statement of changes
Page 51 and 52: Bosnalijek d.d.Notes to financial s
Page 65 and 66: Bosnalijek d.d.Statement of income
Page 67 and 68: • Finances Department DirectorMir
Page 69 and 70:
Middle East and Africa Region• Ag
Page 71 and 72:
®Registeredname/INNNOMIGREN N®cof
show all

ANNUAL REPORT 06 - Bosnalijek dd

Create successful ePaper yourself

Delete template?

Save as template?